Search - tctmd.com

Displaying 81 - 100 of 378

Sort: Relevancy | Date

Presentation NY Valves 2025

Terminology and Important Design Features and Second Valve Options

Presenter: Gilbert H. L. Tang

June 26, 2025

Presentation NY Valves 2025

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Presenter: Nirat Beohar

June 26, 2025

Presentation NY Valves 2025

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Presenter: Susheel K. Kodali

June 26, 2025

Presentation NY Valves 2025

Management of Valve Balloon Rupture: a Case-Based Tutorial

Presenter: Itsik Ben-Dor

June 26, 2025

Presentation NY Valves 2025

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Presenter: Takayuki Onishi

June 26, 2025

Presentation NY Valves 2025

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Presenter: Chloe Kharsa

June 26, 2025

Presentation NY Valves 2025

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Presenter: Matteo Sturla

June 26, 2025

Presentation NY Valves 2025

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Presenter: Yasemin Ciftcikal

June 26, 2025

Presentation NY Valves 2025

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Presenter: Srivatsan Swaminathan

June 26, 2025

Presentation NY Valves 2025

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Presenter: Rodney Horton

June 26, 2025

Presentation NY Valves 2025

Surgical vs. Medical Treatment of Post-TAVR Endocarditis: A Meta-Analysis of Outcomes and Insights From Contemporary Cohorts

Presenter: Dimitrios Magouliotis

June 26, 2025

Presentation NY Valves 2025

LAAC After TAVR: Key Lessons From WATCH TAVR

Presenter: Samir R. Kapadia

June 26, 2025

Presentation NY Valves 2025

Lifetime Management Considerations

Presenter: Mathew Williams

June 26, 2025

Presentation NY Valves 2025

Precedural Planning of TAVR for Aortic Regurgitation

Presenter: Curtiss T. Stinis

June 26, 2025

Presentation NY Valves 2025

Patient Case Example 2

Presenter: Tanush Gupta

June 26, 2025

Presentation NY Valves 2025

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Presenter: Suzanne J. Baron

June 26, 2025

Presentation NY Valves 2025

Surgery or TAVR for Severe Aortic Regurgitation?

Presenter: Basel Ramlawi

June 26, 2025

Presentation NY Valves 2025

TAVR Across the Age Spectrum

Presenter: Molly Ann Szerlip

June 26, 2025

Presentation NY Valves 2025

Patient Case Example 1

Presenter: Puja B. Parikh

June 26, 2025

Presentation NY Valves 2025

TAVR for Aortic Regurgitation in 2025: An ALIGN-AR and ARTIST Trial Update

Presenter: Duane S. Pinto

June 26, 2025

Advertisement

Terminology and Important Design Features and Second Valve Options

Prognostic Value of Baseline Aortic Valve Gradient in Acute Heart Failure Patients Undergoing TAVR

Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)

Management of Valve Balloon Rupture: a Case-Based Tutorial

Fluoroscopic Evaluation of Sapien 3 Movement in Short-in-Tall Redo-TAVR: A First-in-Human Analysis

Redo TAVR Using SAPIEN 3 in Degenerated ACURATE Neo

Percutaneous or Surgical Trans-Axillary Access for TAVR With Hostile Femoral Access: Insights From the HOSTILE Registry

Balloon Assisted Shortening of TAVR Valve: Reducing Risk of Coronary Obstruction

Optimizing Outflow During Redo-TAVR With a 23 mm Sapien UR for a Degenerated Evolut PRO 26 mm Valve

Keynote: The Case for Tandem or Staged AF Ablation and LAAC: Beyond OPTION

Surgical vs. Medical Treatment of Post-TAVR Endocarditis: A Meta-Analysis of Outcomes and Insights From Contemporary Cohorts

LAAC After TAVR: Key Lessons From WATCH TAVR

Lifetime Management Considerations

Precedural Planning of TAVR for Aortic Regurgitation

Patient Case Example 2

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Surgery or TAVR for Severe Aortic Regurgitation?

TAVR Across the Age Spectrum

Patient Case Example 1

TAVR for Aortic Regurgitation in 2025: An ALIGN-AR and ARTIST Trial Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content